126 results
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
% Change
Cost of Commercial product sales
Cost of MCM product sales
Cost of Bioservices
Research and development (“R&D”)
Selling, general … Expenses
For Q1 2024, R&D expenses decreased $25.6 million, or 63%, as compared with Q1 2023. The decrease was primarily due to the sale of our development
8-K
EX-99.2
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
R&D $ Q1 2024 Q1 2023 $52.1 $45.8 $62.2 $55.4 $30.3 $51.7
Segment Reporting Q1 2024 vs. Q1 20231 11 Revenue Segment Adjusted Gross Margin 2 … ) Q2 2024 Forecast Total revenues $160 - $210 Key Assumptions ($ and shares in millions) Updated Range (as of 05/01/2024) Interest expense ~$82 R&D ~6
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
Goodwill impairment
NM
Research and development (“R&D”)
Selling, general and administrative (“SG&A”)
Amortization of intangible assets
Total … at the Company’s Camden and Winnipeg facilities.
Research and Development Expenses
For Q4 2023, R&D expenses decreased $17.6 million, or 37
8-K
EX-99.2
vky49a8 si25b8
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
8-K
EX-99.2
1mmuz jim50v9
9 Jan 24
Regulation FD Disclosure
8:40am
8-K
EX-99.1
nky yquphg2qs
8 Nov 23
Emergent Biosolutions Reports Third Quarter 2023 Financial Results
4:21pm
8-K
EX-99.2
5g3c 47fpr3dt
8 Nov 23
Emergent Biosolutions Reports Third Quarter 2023 Financial Results
4:21pm
8-K
EX-99.2
flvk9d33dzn069v v97o
8 Aug 23
Emergent Biosolutions Reports Financial Results for Second Quarter 2023
4:12pm
8-K
EX-99.1
n2g1q kkh
8 Aug 23
Emergent Biosolutions Reports Financial Results for Second Quarter 2023
4:12pm
8-K
EX-99.2
42zsj
9 May 23
Emergent Biosolutions Reports Financial Results for First Quarter 2023
4:05pm
8-K
EX-99.1
g3inap
9 May 23
Emergent Biosolutions Reports Financial Results for First Quarter 2023
4:05pm
DEFR14A
zq2epd13mvtv
24 Apr 23
Revised proxy
9:32am